We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

32 hedge funds and large institutions have $590K invested in AIM ImmunoTech in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 32 → 32 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

36% less capital invested

Capital invested by funds: $919K → $590K (-$329K)

Holders
32
Holders Change
–
Holders Change %
0%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$73.3K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$10.8K
3
Renaissance Technologies
Renaissance Technologies
New York
+$9.26K
4
CGA
Crescent Grove Advisors
Illinois
+$7.29K
5
XT
XTX Topco
Cayman Islands
+$5.51K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$49.9K
2
TSS
Two Sigma Securities
New York
-$8.15K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$7.53K
4
VF
Virtu Financial
New York
-$7K
5
HF
HRT Financial
New York
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$298K +$73.3K +4,561 +23%
BlackRock
2
BlackRock
New York
$85.4K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$65K +$10.8K +674 +15%
Renaissance Technologies
4
Renaissance Technologies
New York
$38.9K +$9.26K +576 +22%
State Street
5
State Street
Massachusetts
$21.2K – – –
Verition Fund Management
6
Verition Fund Management
Connecticut
$19.8K -$1.45K -90 -5%
Northern Trust
7
Northern Trust
Illinois
$10.4K – – –
XT
8
XTX Topco
Cayman Islands
$10.2K +$5.51K +343 +70%
Morgan Stanley
9
Morgan Stanley
New York
$9.33K – – –
Citadel Advisors
10
Citadel Advisors
Florida
$5.95K -$49.9K -3,106 -86%
CGA
11
Crescent Grove Advisors
Illinois
$5.55K +$7.29K +454 New
SWM
12
SeaCrest Wealth Management
New York
$4.29K – – –
TSS
13
Two Sigma Securities
New York
$2.53K -$8.15K -507 -71%
CAPTRUST Financial Advisors
14
CAPTRUST Financial Advisors
North Carolina
$2.45K – – –
JWCA
15
J.W. Cole Advisors
Florida
$1.83K +$2.41K +150 New
TRCT
16
Tower Research Capital (TRC)
New York
$1.75K -$64 -4 -3%
CB
17
Community Bank
New York
$1.59K – – –
DBRC
18
D.B. Root & Company
Pennsylvania
$1.47K – – –
TCM
19
Traynor Capital Management
Pennsylvania
$1.44K – – –
HWM
20
HB Wealth Management
Georgia
$1.22K – – –
UBS Group
21
UBS Group
Switzerland
$951 +$1.25K +78 New
HI
22
Hoey Investments
Pennsylvania
$123 – – –
HI
23
Harbour Investments
Wisconsin
$122 +$161 +10 New
Osaic Holdings
24
Osaic Holdings
Arizona
$120 – – –
Bank of America
25
Bank of America
North Carolina
$61 – – –
1
2

AIM Hedge Fund Activity: Q1 2025 in Review

32 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q1 2025, worth a combined $590K — down 36% from $919K a quarter earlier.

Fund positioning in AIM was balanced in Q1 2025: 6 funds opened new positions, 6 closed out, 4 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $73.3K. The largest seller was Citadel Advisors, cutting an estimated $49.9K.

  • 32 institutional investors held AIM ImmunoTech (AIM) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $590K of AIM ImmunoTech stock for Q1 2025, down 36% quarter-over-quarter.
  • 6 funds opened new AIM ImmunoTech positions in Q1 2025 and 6 closed out, a net change of 0 holders.
  • The largest AIM ImmunoTech buyer in Q1 2025 was Vanguard Group, an estimated $73.3K added.
  • The largest AIM ImmunoTech seller in Q1 2025 was Citadel Advisors, an estimated $49.9K sold.

Based on aggregated 13F filings for Q1 2025.